Summary Cytogenetic analysis was carried out on peripheral blood cultures from seven patients with acute promyelocytic leukaemia . A reciprocal 15;17 chromosome translocation, t(lSq +; 17q -), was found in all cases, and the breakpoints estimated to be 15q22 and 17ql2-21. In addition to the t(15q+;17q-), trisomy 10 was found in 50% of cells analysed in one case. These results suggest that the 15;17 chromosome translocation may be observed in most cases of APL where the leukaemic cells are cultured before cytogenetic analysis is performed. The use of conditioned media in the culture of leukaemic cells is also described.
Acute promyelocytic leukaemia (FAB-classification M3) is characterised by marked haemorrhagic episodes, disseminated intravascular coagulation, and infiltration of the bone marrow with abnormal promyelocytes containing heavy azurophilic granulation. Some promyelocytes contain multiple Auer rods (Bennett et al., 1976) . A morphological variant of APL has been recognised with the same clinical features as APL (called microgranular APL or M3-variant) in which the leukaemic cells have abnormal bilobed, multilobed or reniform nuclei, and are either devoid of granules or have a few fine azurophilic granules (Bennett et al., 1980; McKenna et al., 1982) .
An abnormal chromosome 17 was first recognised in the leukaemic cells of APL patients by Golomb et al. (1976) , and subsequently shown to result from a balanced 15q +; 17q -chromosome translocation (Rowley et al., 1977a; Golomb et al., 1979) . This translocation has since been identified in both the the typical and variant forms of APL, with the data collected at the Second International Workshop on Chromosomes on Leukemia, 1979 Leukemia, (1980 suggesting a geographic variation in the incidence 1 5q +; 17q-chromosome translocation in APL. More recently, however, by analysing whether cells have been cultured prior to chromosome preparation, it has been shown that the apparently uneven geographic distribution can probably be accounted for by methodological differences in chromosome preparation (Berger et al., 1980 ; Fourth International Workshop on Chromosomes in Leukemia 1982 Leukemia , 1984 on Chromosomes in Leukemia, 1982 Leukemia, (1984 , and none of these showed the 15q+;17q-chromosome translocation. There has only been one report of a case of APL in England showing this translocation (Sheer et al., 1982) . Cytogenetic findings are now presented on a further seven patients with this disease. In addition, the use of conditioned media for obtaining chromosome preparations from frozen leukaemic cells is described.
Materials and methods
Patients were diagnosed as having APL (M3) on the basis of FAB criteria. Clinical details of patients at the time of diagnosis are summarised in Table I . None of the patients had received therapy prior to peripheral blood samples being taken. Peripheral blood leukocytes from three patients had been frozen in liquid nitrogen for 2-3 years prior to cytogenetic analysis. Samples were cultured for 24 to 96 h in RPMI 1640, 20% foetal calf serum, 0.03% glutamine and 20 u ml1 heparin. Conditioned medium from 7-day cultures of PHAstimulated peripheral blood lymphocytes (PHA-LCM) and of the human bladder carcinoma cell line 5637 (5637-CM), which has been shown to secrete growth factors for myeloid cells (Myers et al., 1984) was added to most cultures to a final concentration of 10% (Table II) . Ethidium bromide was added to cultures from all patients except JD and IL, together with colcemid for 1-1.5h prior to chromosome harvest, to a final concentration of lOgmlP1 (Ikeuchi & Sasaki, 1979) . Chromosomes were prepared according to standard procedures and chromosome abnormalities identified by Gbanding (Seabright, 1971 ) and Q-banding (Caspersson et al., 1971) . Ten to twenty metaphase spreads were analyzed in each case.
k) The Macmillan Press Ltd., 1985 A typical 1 Sq +; 17q -chromosome translocation was found in every case (Table II) . The chromosome breakpoints in one patient (J.D.) were localised to 15q22 and 17ql2-21 by genetic analysis of an interspecific somatic cell hybrid containing the 15q+ translocation chromosome (Sheer et al., 1983) . No other clonal chromosome abnormalities were found, other than trisomy 10 which was present in 50% of metaphases analysed in one patient. Figure 1 shows a representative karyotype from one patient. Cytogenetic analysis was attempted on frozen blood samples from a total of 6 patients with APL. No dividing cells were obtained from 3 of these samples where no conditioned medium was added (data from three successful cultures shown in Table  II ). As we were also unable to obtain dividing cells Figure 1 Q-banded Leukemia, 1979 Leukemia, (1980 , was investigated at the Fourth International Workshop on Chromosomes in Leukemia, 1982 Leukemia, (1984 . The percentage of bone marrow samples which had clonal karyotypically abnormal cells rose from 44% in direct preparations, to 66% in 24-48 h cultures, to 80% in cultures exposed to methotrexate. In addition, the 15q +; 17q -chromosome translocation was found in 20% more cases (70% total) than at the Second Workshop. These results, and those of others (e.g. Yunis, 1982) show that high resolution banding techniques allow better visualisation of the rearranged chromosomes, and that a period of in vitro culture substantially increases the likelihood of detecting a karyotypically abnormal clone. Berger et al. (1980) have suggested that the dividing cells in direct preparations from APL may be erythroblasts with few dividing cells were found in the third frozen sample, EB, with PHA-LCM after 24h in culture and these all showed a normal karyotype. It is possible that these were normal cells stimulated to divide by the PHA in the conditioned medium. When the sample from EB was cultured in medium containing 5637-CM, however, a large number of dividing cells were found, showing the 15q + ;17q -translocation. We were also able to obtain good chromosome preparations from all our fresh samples with the addition of 5637-CM to the cultures. Finally, the use of ethidium bromide in later chromosome preparations allowed us to obtain elongated chromosomes, thus facilitating the identification of the translocation in these preparations.
The exact locations of the chromosome breakpoints in the 15q+;17q-translocation have been difficult to determine cytologically and have been sited at different positions by different investigators, e.g. 15q22 and 17q21 (Rowley et al., 1977b) and 15q25 and 17q22 (Second International Work- shop on Chromosomes in Leukemia, 1980) . More recently, however, the analysis of elongated chromosomes with R-. Q-and G-banding has resulted in general agreement over the siting of the breakpoints at 15q22, possibly 15q2200, and 17q12-21 (Fourth International Workshop on Chromosomes in Leukemia, 1984; Hagemeijer et al., 1982; Larson et al., 1984) . Analysis of interspecific somatic cell hybrids derived from one APL patient (JD) has confirmed the localisation of the translocation breakpoints to 15q22 and 17ql2-21 (Sheer et al., 1983) .
In addition to the 15; 17 chromosome translocation, trisomy 10 was found in one patient (G.B.) Trisomy 10 is not specifically associated with APL, although it has been previously reported in one case (Brodeur et al., 1983) . Trisomy 10 might be a secondary chromosome aberration in the patient G.B., since it was only observed in 50% of cells analysed.
Our results are in agreement with those of Larson et al. (1984) who found a 15q+;17q-translocation in every one of their 27 patients with APL studied in Chicago. The translocation has not been reported in any other type of malignancy (Mitelman, 1984) , other than in a promyelocytic form of chronic myeloid leukaemia blast crisis (Berger et al., 1983) . The oncogene c-erbAl has been localised immediately proximal to the APL breakpoint on chromosome 17 (Sheer et al., 1985) . The specificity and incidence of the translocation suggest the presence of a gene which plays a role in myeloid differentiation at the promyelocyte stage, at one of the translocation breakpoints on chromosome 15 or 17. The juxtaposition of this gene with sequences from the other translocation chromosome, possibly the oncogene c-erbAl, could play a crucial role in the development of this malignancy.
